pediatric inflammatory multisystem syndrome

pediatric inflammatory multisystem syndrome
Name	Pediatric inflammatory multisystem syndrome
Field	Pediatrics, Infectious disease, Immunology
Symptoms	Fever, rash, conjunctivitis, shock, gastrointestinal symptoms
Complications	Coronary artery aneurysm, myocarditis, multi-organ dysfunction
Onset	Days to weeks after infection
Causes	Post-infectious immune dysregulation
Risks	Prior infection, certain demographic factors
Diagnosis	Clinical criteria, laboratory evidence, imaging
Treatment	Immunoglobulin, corticosteroids, supportive care
Prognosis	Most recover with treatment; some have persistent sequelae

pediatric inflammatory multisystem syndrome is an acute pediatric hyperinflammatory condition temporally associated with antecedent infectious exposures. The syndrome manifests with systemic inflammation, variable cardiovascular compromise, mucocutaneous findings, and gastrointestinal symptoms, often requiring multidisciplinary care. Early recognition by clinicians and coordinated management across pediatric centers can reduce morbidity and mortality.

Introduction

First described during global outbreaks that engaged World Health Organization surveillance and prompted alerts from Centers for Disease Control and Prevention and national health agencies, the syndrome drew attention from pediatricians in tertiary centers such as Great Ormond Street Hospital and research groups at institutions like Johns Hopkins Hospital and Mayo Clinic. Case series reported by teams at University College London Hospitals, Boston Children's Hospital, and University of Melbourne prompted collaborations with laboratories at Imperial College London and Harvard Medical School to characterize clinical patterns. Professional societies including the American Academy of Pediatrics, Royal College of Paediatrics and Child Health, and European Centre for Disease Prevention and Control issued interim guidance while cohorts were enrolled in studies at Queen Mary University of London and Stanford University.

Epidemiology and Risk Factors

Epidemiologic reports from regions such as Lombardy, New York City, Lagos, Mumbai, and Sao Paulo documented temporal clustering following waves in Wuhan, Lyon, and Madrid, leading surveillance teams from Public Health England and Centers for Disease Control and Prevention to compile case definitions. Large registries coordinated by consortia at University of California, San Francisco, University of Toronto, Karolinska Institutet, and Auckland District Health Board identified demographic associations reported in cohorts from Seattle, Chicago, Manchester, and Barcelona. Risk factor analyses by research groups at Columbia University, Yale University, and University of Oxford implicated prior exposure detected by serology platforms developed at Institut Pasteur and The Francis Crick Institute, with variation noted across populations studied by teams at National University of Singapore and King's College London.

Clinical Presentation and Diagnosis

Clinical series from hospitals such as Royal Children's Hospital, Melbourne, Children's Hospital of Philadelphia, and Great Ormond Street Hospital described presentations including fever, conjunctivitis, rash, mucosal changes, hypotension, and abdominal pain requiring imaging from departments at Mayo Clinic and Cleveland Clinic. Diagnostic protocols were informed by criteria published by Centers for Disease Control and Prevention, World Health Organization, and national pediatric societies like Society for Critical Care Medicine and American College of Cardiology for cardiac evaluation. Laboratory evaluation using platforms from Abbott Laboratories, Roche, and Beckman Coulter measured markers such as C-reactive protein, ferritin, and troponin, while echocardiography performed by teams at Mount Sinai Hospital assessed ventricular function and coronary dimensions. Differential diagnosis included conditions studied at Johns Hopkins Hospital and University College London such as Kawasaki disease, toxic shock syndrome, and macrophage activation syndrome described in literature from National Institutes of Health and European Society of Cardiology.

Pathophysiology and Immunology

Investigations by immunology groups at Massachusetts General Hospital, University of Cambridge, and Max Planck Institute explored dysregulated host responses mediated by cytokines characterized in work from La Jolla Institute for Immunology and Scripps Research. Studies applying techniques pioneered at Broad Institute and Wellcome Trust Sanger Institute assessed genetic susceptibility, while virology labs at Pasteur Institute and Fujita Health University examined temporal relationships with antecedent viral exposures detected using assays standardized by World Health Organization reference centers. Research implicating innate and adaptive immune activation referenced cytokine profiles described in publications from National Institute of Allergy and Infectious Diseases, Cold Spring Harbor Laboratory, and NIAID Vaccine Research Center.

Management and Treatment

Management pathways developed at institutions such as Great Ormond Street Hospital, Boston Children's Hospital, and Children's Hospital Colorado involve immunomodulation with intravenous immunoglobulin from suppliers like Grifols and corticosteroids per protocols informed by multicenter trials coordinated by National Institutes of Health, European Medicines Agency, and academic networks at University of Pennsylvania and Vanderbilt University Medical Center. Supportive critical care, vasoactive support, and extracorporeal membrane oxygenation employed in refractory shock were reported by centers including Texas Children's Hospital, Sheba Medical Center, and Royal Brompton Hospital. Antithrombotic strategies referenced guidelines from American Heart Association and International Society on Thrombosis and Haemostasis, while follow-up frameworks were implemented by pediatric cardiology services at Children's National Hospital and Boston Children's Hospital.

Prognosis and Long-term Outcomes

Outcomes reported in longitudinal cohorts from University of Washington, University of Toronto, Guy's and St Thomas' NHS Foundation Trust, and Barnes-Jewish Hospital indicated that most children recover cardiac function within weeks to months, though some cohorts in Paris and Rome documented persistent coronary changes requiring surveillance by clinics at Great Ormond Street Hospital and Children's Hospital Los Angeles. Long-term follow-up studies coordinated by National Children's Study-affiliated networks and registries at Pediatric Heart Network are assessing neurodevelopmental, cardiovascular, and psychosocial outcomes with involvement from institutions like Harvard T.H. Chan School of Public Health and Johns Hopkins Bloomberg School of Public Health. Continued international collaboration among public health agencies such as World Health Organization, Centers for Disease Control and Prevention, and national ministries of health aims to refine prevention, recognition, and care pathways.

Category:Pediatrics